Portugal, July 24 -- Portugal based LILLY PORTUGAL - PRODUTOS FARMACEUTICOS has secured contract from Unidade Local De Saude Amadora/Sintra, E.P.E. for Acquisition Of Ramucirumab Iv 10Mg/Ml 10Ml Con Sol Per Per, Under Cpa 2023/491, For Ulsasi, For The Year 2025. The value of the contract is worth 623670 EUR.
Published by HT Digital Content Services with permission from Pivotal Sources....